Tiziana Life Sciences Ltd (TLSA) Form 8-K Material Events
Tiziana Life Sciences Ltd (TLSA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TLSA
CIK: 1723069
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: D0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PKF Littlejohn LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerDavid Thompson
Audit LocationLondon, United Kingdom
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-10-16 | 2026-10-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-110270 | View SEC Doc Filr Page |
| 6-K | 2026-10-16 | 2026-10-16 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-110008 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-104868 | View SEC Doc Filr Page |
| 4 | 2026-09-29 | 2026-08-15 | 4 Filing | 0001213900-26-104755 | View SEC Doc Filr Page |
| 6-K | 2026-09-28 | 2026-09-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-103735 | View SEC Doc Filr Page |
| 6-K | 2026-09-21 | 2026-09-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-101635 | View SEC Doc Filr Page |
| 6-K | 2026-09-17 | 2026-09-17 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-100742 | View SEC Doc Filr Page |
| 6-K | 2026-08-24 | 2026-08-24 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-092792 | View SEC Doc Filr Page |
| 4/A | 2026-08-07 | 2026-07-21 | 4/A Filing | 0001213900-26-086697 | View SEC Doc Filr Page |
| 4/A | 2026-08-07 | 2026-06-12 | 4/A Filing | 0001213900-26-086696 | View SEC Doc Filr Page |
| 4 | 2026-08-06 | 2026-08-04 | 4 Filing | 0001213900-26-085950 | View SEC Doc Filr Page |
| 6-K | 2026-08-06 | 2026-08-06 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-085904 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-08-03 | 4 Filing | 0001213900-26-085710 | View SEC Doc Filr Page |
| 6-K | 2026-08-04 | 2026-08-04 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-084894 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-083604 | View SEC Doc Filr Page |
| 3 | 2026-07-23 | 2026-03-18 | 3 Filing | 0001213900-26-080890 | View SEC Doc Filr Page |
| 4 | 2026-07-23 | 2026-06-21 | 4 Filing | 0001213900-26-080880 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-07-22 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-080178 | View SEC Doc Filr Page |
| 6-K | 2026-06-25 | 2026-06-25 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-071738 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-12 | 4 Filing | 0001213900-26-069424 | View SEC Doc Filr Page |
| 6-K | 2026-06-15 | 2026-06-15 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-068498 | View SEC Doc Filr Page |
| 6-K | 2026-05-28 | 2026-05-28 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-061726 | View SEC Doc Filr Page |
| 3 | 2026-05-22 | 2026-03-18 | 3 Filing | 0001213900-26-060643 | View SEC Doc Filr Page |
| 6-K | 2026-05-21 | 2026-05-21 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-059919 | View SEC Doc Filr Page |
| 6-K | 2026-05-19 | 2026-05-19 | REPORT OF FOREIGN PRIVATE ISSUER | 0001213900-26-058715 | View SEC Doc Filr Page |